Haematologica 2019 Aug 14
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.
Related Questions
Recurrent thromboses despite therapeutic enoxaparin. Other hypercoagulable work-up negative.
New comment by at Johns Hopkins University ( March 15, 2022)
My thought about the liver as a site of thrombosis in PV is that nitric oxide scavenging by the increased number of red cells is the cause similar to increased nitric oxide sc...
No evidence of palpable splenomegaly, normal hematocrit and platelet count
New answer by at Johns Hopkins University (June 28, 2022)
First, let's abandon the phase "BCR/ABL-negative MPN". This is an oxymoron because BCR/ABL can be expressed in a JAK2 driver mutation-positive MPN. In fact, both BCR/ABL and J...
How do you use this information in clinical practice?
New comment by Medical Oncologist at Aspirus UW Cancer Center ( May 11, 2023)
Great review. Thank you
Do you think it will become first-line therapy? Is potential iron overload a concern with long-term use?
Bankar et al. VERIFY: A randomized controlle...
New answer by at Johns Hopkins University (July 15, 2025)
Rusfertide, an injectable hepcidin mimetic (1), is another new arrow in the quiver of 21st-century therapies for controlling erythropoiesis without phlebotomy in polycythemia ...